Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze ADNT stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate ADNT investment potential.

What is ADNT stock price today?

Get real-time ADNT stock price, historical data, and price charts on Financhill. Track ADNT performance with our advanced analysis tools.

Is ADNT a good investment?

Evaluate ADNT investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy ADNT stock?

To buy ADNT stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of ADNT?

View detailed market capitalization data and company valuation metrics for ADNT on our comprehensive analysis page.

What is the P/E ratio of ADNT?

Use our fundamental analysis tools to view ADNT P/E ratio and compare valuation metrics with industry peers.

What are ADNT earnings?

View ADNT earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Adient plc 10K Form

Buy

ADNT
Adient plc

Last Price:

$20.80

Seasonality Move:

-2.63%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-08-02	10Q	ADNT/Adient plc Quarterly
2023-05-03	10Q	ADNT/Adient plc Quarterly
2023-02-07	10Q	ADNT/Adient plc Quarterly
2022-08-05	10Q	ADNT/Adient plc Quarterly
2022-05-06	10Q	ADNT/Adient plc Quarterly
2022-02-04	10Q	ADNT/Adient plc Quarterly

Receive ADNT News And Ratings

See the #1 stock for the next 7 days that we like better than ADNT

ADNT Financial Statistics

Sales & Book Value

Annual Sales:	$14.5B
Cash Flow:	$134M
Price / Cash Flow:	8.6
Annual Sales:	$22.31
Price / Book:	0.94

Profitability

EPS (TTM):	-3.33660
Net Income (TTM):	$-191M
Gross Margin:	$994M
Return on Equity:	-8.61%
Return on Assets:	-2.16%

Adient plc Earnings Forecast

Key Adient plc Financial Ratios

The Gross Profit Margin over the past 13 years for ADNT is 6.84%.
The Selling, General & Administrative Expenses for ADNT have been equal to 3.59% of Gross Profit Margin.
The Research & Development expenses have been 2.66% of Revenue.
The Net Earning history of ADNT is -1.31% of Total Revenues.
Per Share Earnings over the last 13 years have been positive in 6 years.

Adient plc Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NYSE
Industry:	Automobile Components
Sector:	Consumer Discretionary
Current Symbol:	ADNT
CUSIP:	G0084W
Website:	adient.com

Debt

Debt-to-Equity Ratio:	1.5
Current Ratio:	1.12
Quick Ratio:	0.78

Price-to-Earnings

Trailing P/E Ratio:	95
Forward P/E Ratio:	6.92

ADNT Technical Analysis vs Fundamental Analysis

Buy

Adient plc (ADNT) is a Buy

Is Adient plc a Buy or a Sell?

Adient plc stock is rated a Buy

The current Adient plc [ADNT] share price is $21.04. The Score for ADNT is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.